rs141043166

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 1P and 20B. PP3BP4_StrongBP6_Very_StrongBS1BS2

The NM_000642.3(AGL):​c.1481G>A​(p.Arg494His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00828 in 1,613,946 control chromosomes in the GnomAD database, including 95 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R494C) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0072 ( 11 hom., cov: 32)
Exomes 𝑓: 0.0084 ( 84 hom. )

Consequence

AGL
NM_000642.3 missense

Scores

7
7
3

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:13

Conservation

PhyloP100: 7.71

Publications

19 publications found
Variant links:
Genes affected
AGL (HGNC:321): (amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase) This gene encodes the glycogen debrancher enzyme which is involved in glycogen degradation. This enzyme has two independent catalytic activities which occur at different sites on the protein: a 4-alpha-glucotransferase activity and a amylo-1,6-glucosidase activity. Mutations in this gene are associated with glycogen storage disease although a wide range of enzymatic and clinical variability occurs which may be due to tissue-specific alternative splicing. Alternatively spliced transcripts encoding different isoforms have been described. [provided by RefSeq, Jul 2008]
AGL Gene-Disease associations (from GenCC):
  • glycogen storage disease III
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Ambry Genetics, Laboratory for Molecular Medicine, Myriad Women’s Health, Orphanet, G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae), Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

PP3
Multiple lines of computational evidence support a deleterious effect 8: BayesDel_noAF, Cadd, Dann, Eigen, MutationAssessor, phyloP100way_vertebrate, REVEL, REVEL [when AlphaMissense, BayesDel_addAF, max_spliceai, FATHMM_MKL, MetaRNN, MutationTaster was below the threshold]
BP4
Computational evidence support a benign effect (MetaRNN=0.01898399).
BP6
Variant 1-99877698-G-A is Benign according to our data. Variant chr1-99877698-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 256723.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00719 (1094/152200) while in subpopulation NFE AF = 0.00907 (617/68004). AF 95% confidence interval is 0.00848. There are 11 homozygotes in GnomAd4. There are 601 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 11 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000642.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
AGL
NM_000642.3
MANE Select
c.1481G>Ap.Arg494His
missense
Exon 12 of 34NP_000633.2
AGL
NM_000028.3
c.1481G>Ap.Arg494His
missense
Exon 12 of 34NP_000019.2
AGL
NM_000643.3
c.1481G>Ap.Arg494His
missense
Exon 12 of 34NP_000634.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
AGL
ENST00000361915.8
TSL:1 MANE Select
c.1481G>Ap.Arg494His
missense
Exon 12 of 34ENSP00000355106.3
AGL
ENST00000294724.8
TSL:1
c.1481G>Ap.Arg494His
missense
Exon 12 of 34ENSP00000294724.4
AGL
ENST00000370163.7
TSL:1
c.1481G>Ap.Arg494His
missense
Exon 12 of 34ENSP00000359182.3

Frequencies

GnomAD3 genomes
AF:
0.00720
AC:
1095
AN:
152082
Hom.:
11
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00140
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00236
Gnomad ASJ
AF:
0.00231
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00145
Gnomad FIN
AF:
0.0338
Gnomad MID
AF:
0.00318
Gnomad NFE
AF:
0.00907
Gnomad OTH
AF:
0.00478
GnomAD2 exomes
AF:
0.00843
AC:
2119
AN:
251244
AF XY:
0.00874
show subpopulations
Gnomad AFR exome
AF:
0.00105
Gnomad AMR exome
AF:
0.00234
Gnomad ASJ exome
AF:
0.00367
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0309
Gnomad NFE exome
AF:
0.0109
Gnomad OTH exome
AF:
0.00735
GnomAD4 exome
AF:
0.00839
AC:
12269
AN:
1461746
Hom.:
84
Cov.:
32
AF XY:
0.00839
AC XY:
6103
AN XY:
727180
show subpopulations
African (AFR)
AF:
0.000747
AC:
25
AN:
33476
American (AMR)
AF:
0.00266
AC:
119
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.00352
AC:
92
AN:
26130
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39666
South Asian (SAS)
AF:
0.000985
AC:
85
AN:
86256
European-Finnish (FIN)
AF:
0.0301
AC:
1610
AN:
53418
Middle Eastern (MID)
AF:
0.00330
AC:
19
AN:
5766
European-Non Finnish (NFE)
AF:
0.00892
AC:
9916
AN:
1111926
Other (OTH)
AF:
0.00667
AC:
403
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
624
1247
1871
2494
3118
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
354
708
1062
1416
1770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00719
AC:
1094
AN:
152200
Hom.:
11
Cov.:
32
AF XY:
0.00808
AC XY:
601
AN XY:
74414
show subpopulations
African (AFR)
AF:
0.00137
AC:
57
AN:
41522
American (AMR)
AF:
0.00235
AC:
36
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00231
AC:
8
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.00145
AC:
7
AN:
4822
European-Finnish (FIN)
AF:
0.0338
AC:
358
AN:
10588
Middle Eastern (MID)
AF:
0.00342
AC:
1
AN:
292
European-Non Finnish (NFE)
AF:
0.00907
AC:
617
AN:
68004
Other (OTH)
AF:
0.00473
AC:
10
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
54
108
163
217
271
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00761
Hom.:
26
Bravo
AF:
0.00475
TwinsUK
AF:
0.00647
AC:
24
ALSPAC
AF:
0.00908
AC:
35
ESP6500AA
AF:
0.00182
AC:
8
ESP6500EA
AF:
0.00837
AC:
72
ExAC
AF:
0.00888
AC:
1078
Asia WGS
AF:
0.000866
AC:
3
AN:
3478
EpiCase
AF:
0.00780
EpiControl
AF:
0.00699

ClinVar

ClinVar submissions as Germline

Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
5
Glycogen storage disease type III (5)
-
-
4
not provided (4)
-
-
3
not specified (3)
-
-
1
AGL-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.23
BayesDel_addAF
Benign
-0.0040
T
BayesDel_noAF
Pathogenic
0.23
CADD
Pathogenic
27
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.45
T
Eigen
Pathogenic
0.87
Eigen_PC
Pathogenic
0.80
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Uncertain
0.97
D
MetaRNN
Benign
0.019
T
MetaSVM
Pathogenic
0.79
D
MutationAssessor
Pathogenic
3.5
H
PhyloP100
7.7
PrimateAI
Uncertain
0.72
T
PROVEAN
Uncertain
-4.3
D
REVEL
Pathogenic
0.89
Sift
Uncertain
0.0020
D
Sift4G
Uncertain
0.0040
D
Polyphen
1.0
D
Vest4
0.80
MVP
0.94
MPC
0.32
ClinPred
0.049
T
GERP RS
5.1
Varity_R
0.55
gMVP
0.86
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs141043166; hg19: chr1-100343254; COSMIC: COSV54055353; COSMIC: COSV54055353; API